Citadel Advisors’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-200
Closed -$6.01K 15606
2024
Q3
$6.01K Buy
+200
New +$5.51K ﹤0.01% 13449
2024
Q2
Sell
-200
Closed -$5.71K 15649
2024
Q1
$5.71K Buy
200
+167
+506% +$4.77K ﹤0.01% 13726
2023
Q4
$1.01K Buy
+33
New +$885 ﹤0.01% 13897

Other funds holding HEAL

Citadel Advisors's HEAL Position: Q4 2025 in Review

Citadel Advisors sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q4 2025, closing a stake of 6,754 shares — an estimated $216K sold.

Citadel Advisors first reported a position in HEAL in Q3 2020 and held it in 11 quarters. The position peaked at $1.67M in Q3 2021. 28 funds tracked by Wall St. Rank hold HEAL as of Q4 2025.

  • Citadel Advisors reported no remaining Global X Funds Global X HealthTech ETF position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 6,754 Global X Funds Global X HealthTech ETF shares in Q4 2025, an estimated $216K.
  • Citadel Advisors first reported a position in Global X Funds Global X HealthTech ETF in Q3 2020 and held it in 11 quarters.
  • Citadel Advisors's Global X Funds Global X HealthTech ETF position peaked at $1.67M in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.